Kura Oncology

Last updated: February 15, 2024

CEO Troy Wilson
CEO Troy Wilson
Country: USA | Funding: $1.2B (+)

Website: https://www.kuraoncology.com/

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.